Ozempic Response Study Reveals Why Some People Lose More Weight
An Ozempic response study has revealed why some people lose more weight than others. Researchers found that eating habits strongly affect treatment results. People who overeat after seeing or smelling tasty food responded better to GLP-1 medicines. However, emotional eaters showed weaker long-term progress during the study. Scientists from Kyoto University and Gifu University followed 92 people with type 2 diabetes for one year. The participants had recently started GLP-1 treatments like Ozempic. Researchers tracked body weight, blood sugar, cholesterol, and eating behaviors throughout the trial.
Eating Habits Changed Treatment Results
The study focused on three common eating patterns. Emotional eating happens when people eat because of stress or sadness. External eating occurs when food looks or smells tempting. Restrained eating involves limiting food intake to lose weight.Researchers discovered that external eaters achieved stronger results. These participants lost more weight and improved blood sugar control over time. In addition, they reduced unhealthy eating habits during the full year.Scientists believe GLP-1 medicines work better for people influenced by food signals. Therefore, the drugs may directly reduce cravings caused by attractive food.
Emotional Eaters Saw Smaller Benefits
The study showed different results for emotional eaters. Many participants initially improved their eating habits after treatment started. However, emotional eating patterns later returned for several people. Researchers explained that emotions may drive these habits more deeply. As a result, medicine alone may not fully solve the problem. Experts say emotional eaters could benefit from therapy or behavioral support alongside medication. The findings appeared in Frontiers in Clinical Diabetes and Healthcare. Scientists also noted that the study was observational and relatively small. Therefore, larger studies are still needed before doctors change treatment plans. Even so, the research may help doctors personalize obesity and diabetes care in the future.
